View in EDS HTML Full Text PDF Full Text

Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors.

Saved in:
Bibliographic Details
Title: Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors.
Authors: Magbanua MJM; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA. mark.magbanua@ucsf.edu., Manon NA; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Wolf DM; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Rivero-Hinojosa S; Natera Inc., Austin, TX, USA., Ahmed Z; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Sayaman RW; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Tin A; Natera Inc., Austin, TX, USA., Renner D; Natera Inc., Austin, TX, USA., Kalashnikova E; Natera Inc., Austin, TX, USA., Brown-Swigart L; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Hirst GL; Department of Surgery, University of California San Francisco, San Francisco, CA, USA., Yau C; Department of Surgery, University of California San Francisco, San Francisco, CA, USA., Li W; Department of Radiology, University of California San Francisco, San Francisco, CA, USA., Isaacs C; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA., Shatsky RA; Department of Medicine, University of California San Diego, La Jolla, CA, USA., Clark AS; Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA, USA., Zimmer A; Division of Hematology/Oncology, Oregon Health and Science University, Portland, OR, USA., Delson AL; Breast Science Advocacy Core, University of California San Francisco, San Francisco, CA, USA., Rodriguez A; Natera Inc., Austin, TX, USA., Liu MC; Natera Inc., Austin, TX, USA., Pohlmann PR; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Esserman LJ; Department of Surgery, University of California San Francisco, San Francisco, CA, USA., Rugo HS; Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA., DeMichele A; Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA, USA., van 't Veer L; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
Source: Nature communications [Nat Commun] 2025 Dec 09; Vol. 16 (1), pp. 9945. Date of Electronic Publication: 2025 Dec 09.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41365872
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Magbanua+MJM%22">Magbanua MJM</searchLink>; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA. mark.magbanua@ucsf.edu.<br /><searchLink fieldCode="AU" term="%22Manon+NA%22">Manon NA</searchLink>; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Wolf+DM%22">Wolf DM</searchLink>; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Rivero-Hinojosa+S%22">Rivero-Hinojosa S</searchLink>; Natera Inc., Austin, TX, USA.<br /><searchLink fieldCode="AU" term="%22Ahmed+Z%22">Ahmed Z</searchLink>; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Sayaman+RW%22">Sayaman RW</searchLink>; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Tin+A%22">Tin A</searchLink>; Natera Inc., Austin, TX, USA.<br /><searchLink fieldCode="AU" term="%22Renner+D%22">Renner D</searchLink>; Natera Inc., Austin, TX, USA.<br /><searchLink fieldCode="AU" term="%22Kalashnikova+E%22">Kalashnikova E</searchLink>; Natera Inc., Austin, TX, USA.<br /><searchLink fieldCode="AU" term="%22Brown-Swigart+L%22">Brown-Swigart L</searchLink>; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hirst+GL%22">Hirst GL</searchLink>; Department of Surgery, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Yau+C%22">Yau C</searchLink>; Department of Surgery, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Li+W%22">Li W</searchLink>; Department of Radiology, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Isaacs+C%22">Isaacs C</searchLink>; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Shatsky+RA%22">Shatsky RA</searchLink>; Department of Medicine, University of California San Diego, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Clark+AS%22">Clark AS</searchLink>; Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Zimmer+A%22">Zimmer A</searchLink>; Division of Hematology/Oncology, Oregon Health and Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Delson+AL%22">Delson AL</searchLink>; Breast Science Advocacy Core, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Rodriguez+A%22">Rodriguez A</searchLink>; Natera Inc., Austin, TX, USA.<br /><searchLink fieldCode="AU" term="%22Liu+MC%22">Liu MC</searchLink>; Natera Inc., Austin, TX, USA.<br /><searchLink fieldCode="AU" term="%22Pohlmann+PR%22">Pohlmann PR</searchLink>; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Esserman+LJ%22">Esserman LJ</searchLink>; Department of Surgery, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Rugo+HS%22">Rugo HS</searchLink>; Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22DeMichele+A%22">DeMichele A</searchLink>; Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22van+'t+Veer+L%22">van 't Veer L</searchLink>; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2025 Dec 09; Vol. 16 (1), pp. 9945. <i>Date of Electronic Publication: </i>2025 Dec 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41365872
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-025-65432-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 9945
    Titles:
      – TitleFull: Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Magbanua MJM
      – PersonEntity:
          Name:
            NameFull: Manon NA
      – PersonEntity:
          Name:
            NameFull: Wolf DM
      – PersonEntity:
          Name:
            NameFull: Rivero-Hinojosa S
      – PersonEntity:
          Name:
            NameFull: Ahmed Z
      – PersonEntity:
          Name:
            NameFull: Sayaman RW
      – PersonEntity:
          Name:
            NameFull: Tin A
      – PersonEntity:
          Name:
            NameFull: Renner D
      – PersonEntity:
          Name:
            NameFull: Kalashnikova E
      – PersonEntity:
          Name:
            NameFull: Brown-Swigart L
      – PersonEntity:
          Name:
            NameFull: Hirst GL
      – PersonEntity:
          Name:
            NameFull: Yau C
      – PersonEntity:
          Name:
            NameFull: Li W
      – PersonEntity:
          Name:
            NameFull: Isaacs C
      – PersonEntity:
          Name:
            NameFull: Shatsky RA
      – PersonEntity:
          Name:
            NameFull: Clark AS
      – PersonEntity:
          Name:
            NameFull: Zimmer A
      – PersonEntity:
          Name:
            NameFull: Delson AL
      – PersonEntity:
          Name:
            NameFull: Rodriguez A
      – PersonEntity:
          Name:
            NameFull: Liu MC
      – PersonEntity:
          Name:
            NameFull: Pohlmann PR
      – PersonEntity:
          Name:
            NameFull: Esserman LJ
      – PersonEntity:
          Name:
            NameFull: Rugo HS
      – PersonEntity:
          Name:
            NameFull: DeMichele A
      – PersonEntity:
          Name:
            NameFull: van 't Veer L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 12
              Text: 2025 Dec 09
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1